AIM2 inflammasomes scores were significantly increased in cancer samples than in normal samples, including in BLCA, CESC, COAD, DLBC, ESCA, GBM, HNSC, KIRC, KIRP, LAML, LGG, LIHC, OV, PAAD READ, SKCM, STAD, and TGCT (all P < 0.05). This evidence concerns the gene AIM2 and bladder transitional cell carcinoma.